Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Liposomal gemcitabine in combination with pembrolizumab ...

Thank you to all those who helped us in any way. “Having raised the money that we needed to start the Pembro treatment, we felt like at least we had a hope. “It would at least slow down the ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

“Efti+pembro may provide a chemo-free option with similar (close enough) response rates as chemo-containing treatments but a better safety profile,” they said, pointing out that chemo ...

Now, let me remind you what B36 is. It's a phase 2 study in first-line non-small cell lung cancer with monotherapy of pembro.

Agenus has frequently indulged in numerous expensive early-stage trials and has licensed the majority of its pipeline for ...

first-in-class and best-in-class the Phase 1b data for NC410 combo with pembro to be presented at ASCO annual meeting on June 1Presented preclinical data from LNCB74 (B7-H4 ADC) at recent AACR ...

These abstracts are just a few representative abstracts from this track. Pembrolizumab (pembro) monotherapy for patients (pts) with high-risk non–muscle-invasive bladder cancer (HR NMIBC) unresponsive ...

A new treatment for a small number of bowel cancer patients is now being used at Ipswich Hospital - and it is starting to show encouraging results for some who have run out of other options.

Verheij et al. Long-term outcomes of pembrolizumab (pembro) in combination with gemcitabine (gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for ...